These results indicated that Rack1 mutagenesis might be involved in the pathogenesis and progression of several types of brain tumors, such as gliomas and neuroblastoma,52, 53 therefore, more detailed mutation sites and the underlying signaling mechanisms of Rack1 in brain tumors need further characterization and investigation. This evidence concerns the gene RACK1 and central nervous system cancer.